These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2939532)

  • 1. Interferon-gamma plays a crucial role in T lymphocyte reaction against alloantigens.
    Landolfo S; Cofano F; Giovarelli M; Prat M; Cavallo G; Forni G
    Ric Clin Lab; 1985; 15(4):307-14. PubMed ID: 2939532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two distinct populations of primary cytotoxic cells infiltrating into allografted tumor rejection sites: infiltration of macrophages cytotoxic against allografted tumor precedes that of multiple sets of cytotoxic T lymphocytes with distinct specificity to alloantigens.
    Yoshida R; Matsuura A; Einaga K; Ushio Y; Yamamoto N; Yoneda Y
    Microbiol Immunol; 1997; 41(2):149-59. PubMed ID: 9087957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of interferon-gamma may suppress allograft reactivity by T lymphocytes in vitro and in vivo.
    Landolfo S; Cofano F; Giovarelli M; Prat M; Cavallo G; Forni G
    Science; 1985 Jul; 229(4709):176-9. PubMed ID: 3160110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloantigen-specific cytotoxic and suppressor T lymphocytes are derived from phenotypically distinct precursors.
    Damle NK; Mohagheghpour N; Hansen JA; Engleman EG
    J Immunol; 1983 Nov; 131(5):2296-300. PubMed ID: 6195259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of two distinct regulatory T cell populations in the antigen-specific suppression of cytolytic T cell generation.
    Devens BH; Koontz AW; Kapp JA; Pierce CW; Webb DR
    J Immunol; 1991 Mar; 146(5):1394-401. PubMed ID: 1825218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of in vitro cytotoxic T lymphocyte generation. II. Demonstration of noncytotoxic alloantigen-specific suppressor T lymphocytes.
    Schwartz A; Sutton SL; Gershon RK
    Eur J Immunol; 1982 May; 12(5):380-6. PubMed ID: 6212258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of donor-specific T cell anergy by portal venous injection of allogeneic cells.
    Sugiura K; Kato K; Hashimoto F; Jin T; Amoh Y; Yamamoto Y; Morita H; Okumura K; Ikehara S
    Immunobiology; 1997 Nov; 197(5):460-77. PubMed ID: 9413746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vivo immunosuppressive action of suppressor cells from alloantigen-cyclosporine-treated mice and the capacity of spleen cells to release interleukins and gamma-interferon.
    Yoshimura N; Matsui S; Hamashima T; Kita M; Oka T
    Transplantation; 1988 Jan; 45(1):157-62. PubMed ID: 2962348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4 help-independent induction of cytotoxic CD8 cells to allogeneic P815 tumor cells is absolutely dependent on costimulation.
    Zhan Y; Corbett AJ; Brady JL; Sutherland RM; Lew AM
    J Immunol; 2000 Oct; 165(7):3612-9. PubMed ID: 11034363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Search for class II major histocompatibility complex molecular involvement in the response of Lyt-2+ cytotoxic T lymphocyte precursors to alloantigen.
    Romani L; Mage MG
    Eur J Immunol; 1985 Nov; 15(11):1125-30. PubMed ID: 2933265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-LFA-1 (CD11a) monoclonal antibody interferes with neonatal induction of tolerance to alloantigens.
    Schurmans S; Gonzalez A; Revilla C; Ramos A; Lambert PH; Merino J
    Eur J Immunol; 1994 Apr; 24(4):985-90. PubMed ID: 7908637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory mechanisms in cytotoxic T lymphocyte development. II. Dissociation of in vitro cytotoxic T-lymphocyte and suppressor T-cell activities with L-ornithine.
    Susskind BM; Schall R; Dixon ED
    Cell Immunol; 1986 Sep; 101(2):512-23. PubMed ID: 2944613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new type of genetic regulation of allogeneic response. A novel locus on mouse chromosome 4, Alan2 controls MLC reactivity to three different alloantigens: C57BL/10, BALB/c and CBA.
    Havelková H; Badalová J; Demant P; Lipoldová M
    Genes Immun; 2000 Dec; 1(8):483-7. PubMed ID: 11197689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of cytotoxic lymphocyte responses in vitro by soluble products of alloantigen-activated spleen cells.
    Truitt GA; Rich RR; Rich SS
    J Immunol; 1978 Sep; 121(3):1045-51. PubMed ID: 151115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloantigen-activated lymphocytes from mice bearing a spontaneous "nonimmunogenic" adenocarcinoma inhibit its growth in vivo by recruiting host immunoreactivity.
    Giovarelli M; Santoni A; Forni G
    J Immunol; 1985 Nov; 135(5):3596-603. PubMed ID: 3930610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of anti-Lyt antibodies on T-cell functions.
    Hollander N
    Immunol Rev; 1982; 68():43-66. PubMed ID: 6217147
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppressor T cell recognition of major and minor histocompatibility alloantigens: selected suppression of MHC-directed responses by minor alloantigen Ts.
    Perry LL; Williams IR; Dirusso S
    J Immunol; 1984 Jul; 133(1):16-23. PubMed ID: 6202781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
    Harada M; Matsuzaki G; Yoshikai Y; Kobayashi N; Kurosawa S; Takimoto H; Nomoto K
    Cancer Res; 1993 Jan; 53(1):106-11. PubMed ID: 8093229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.